In Print
Photo by Graham Ramsay
From Focus:
Attacking
Cancer’s Sweet Tooth May Be Effective Against Tumors
An ancient avenue for producing cell energy, the sugar-metabolizing glycolytic
pathway, could provide a rich target for anticancer therapies. Valeria Fantin
(left), Julie St-Pierre, and Philip Leder (right) knocked down one of the pathway’s
enzymes in a variety of breast cancer cells, shutting down glycolysis. Then they
implanted the cells in mice. Control animals carrying tumor cells with an intact
pathway did not survive beyond ten weeks. In contrast, only two of the enzyme-deficient
mice died, and 80 percent of them outlived the four-month experiment.
Lab Works
A multimedia site featuring Harvard
Medical research.
StudenTalk
Personal takes on issues inside and
outside the classroom.
|
|
Spotlight
PME Launches Revamped Website
The Program in Medical Education has redesigned its website, now featuring
descriptions of key components and resources for students and faculty.
Student Scene
Photo by Patrick Ladapo
Grave New World: Gene-doping
in Sports
What may be a boon to patients—gene therapy—could also undermine
sports, says Joseph Ladapo. If therapeutic techniques are exploited to enhance
athletic performance, everyone will be a loser.
|
